Hints and tips:
...Janssen is the pharmaceutical division of J&J....
...And I take my bra off or pull the cups down and I jiggle my shoulders while saying, ‘T-h-a-n-k-y-o-u,’” she says, making her voice go jittery and giving a brief shimmy. “It’s very cute....
...Not only was the BioNTech/Pfizer vaccine the first to be deployed but it has suffered less from rare side effects and manufacturing glitches than its big western rivals Oxford/AstraZeneca, Janssen or Moderna...
...A booster shot of Johnson & Johnson’s Covid-19 vaccine produced a strong and rapid antibody response against the virus, the pharmaceutical company said on Wednesday....
...“The Janssen vaccine will be another weapon in our arsenal to beat this pandemic,” said vaccines minister Nadhim Zahawi....
...Last week, J&J published interim data that showed its vaccine had a 66 per cent efficacy rate for preventing moderate and severe disease, lower than the first shots approved from BioNTech/Pfizer and Moderna...
...multiple clinical trials.Johan Van Hoof, global therapeutic area head at Janssen, J&J’s pharmaceutical division, told the panel on Friday: “Janssen’s vaccine candidate would play a critical role in the...
...“At present, no clear causal relationship has been established between these rare events and the Janssen [J&J] Covid-19 vaccine,” it said, adding that it was working closely with experts and regulators to...
...J&J is preparing to test a new formulation that could be targeted at the 501.v2 variant, but Mathai Mammen, global head of research and development for Janssen, J&J’s pharmaceuticals division, said he was...
...J&J’s deal follows a similar move by the French pharmaceutical group Sanofi, which on Monday said it had agreed to buy San Francisco-based Principia Biopharma in a $3.4bn deal....
...Through its Janssen subsidiary, the New Jersey-based drugmaker will administer its experimental vaccine to 6,000 UK volunteers in two doses in a phase-3 trial....
...He joined Janssen, J&J’s pharma division, in sales in 1988, with only a BA in biology....
...K&L Gates has recruited Richard Hayes as a partner in its Sydney office. He joins from Hogan Lovells....
...by Mr Lee — K-pop....
...Mark Crossley, Indivior’s chief financial and operations officer, will replace Shaun Thaxter as chief executive of the pharmaceutical company....
...J&J — best known for consumer products such as “no more tears” baby shampoo — owns the Janssen pharmaceuticals business that sold two prescription opioids....
...This is a pity. Like a piquant combination of spices, it should grow on them. IFF specialises in flavours and fragrances used in food, beverages and pharmaceuticals....
...Mathai Mammen, global head of Janssen Research and Development, a subsidiary of Johnson & Johnson, said Spravato was a “unique and innovative medicine” that had the potential to offer “new hope” to the third...
...“We have a vested interest in working with the NHS to remain sustainable as a company,” says Jennifer Lee, director of health economics at Janssen, “ we don’t want to be the Kodak of healthcare ....
...Two leading pharmaceutical companies have warned that the UK must continue to attract top scientific talent if it is to maintain its competitive edge....
...Target: Synageva | Acquirer: Alexion Deal value: $8.4bn | Premium*: 135.7% Alexion Pharmaceuticals paid a huge premium to acquire Synageva....
...In a statement on Wednesday, Scott White, president at Janssen Biotech, a pharmaceuticals unit of J&J, said: “We are effectively competing on value and price and to date, Pfizer has failed to demonstrate...
...“We do not condone the use of our medicines in lethal injections for capital punishment,” Janssen said in a statement....
...Kenneth Frazier, the African-American chief executive of pharmaceuticals group Merck, set off a chain reaction on Monday when he resigned from a manufacturing panel convened by the president....
...The pharmaceutical industry is notable for its absence and trials the sector funds should follow the same example....
International Edition